Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 19.64
(0.46%)
CNY 19.64
(0.46%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 310.18 Million CNY | -11.06% |
| 2022 | 348.77 Million CNY | 3.19% |
| 2021 | 337.99 Million CNY | 21.38% |
| 2020 | 278.44 Million CNY | -6.65% |
| 2019 | 298.29 Million CNY | 28.09% |
| 2018 | 232.88 Million CNY | 25.14% |
| 2017 | 186.1 Million CNY | 44.04% |
| 2016 | 129.2 Million CNY | 9.66% |
| 2015 | 117.82 Million CNY | 18.35% |
| 2014 | 99.55 Million CNY | 41.08% |
| 2013 | 70.56 Million CNY | 31.22% |
| 2012 | 53.77 Million CNY | 44.3% |
| 2011 | 37.26 Million CNY | 102.46% |
| 2010 | 18.4 Million CNY | 75.07% |
| 2009 | 10.51 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 72.02 Million CNY | -6.71% |
| 2024 Q3 | 123.02 Million CNY | 70.81% |
| 2024 Q1 | 77.2 Million CNY | 92.84% |
| 2023 Q4 | 40.03 Million CNY | -67.06% |
| 2023 FY | 310.18 Million CNY | -11.06% |
| 2023 Q1 | 70.47 Million CNY | 319.32% |
| 2023 Q2 | 78.12 Million CNY | 10.85% |
| 2023 Q3 | 121.54 Million CNY | 55.57% |
| 2022 FY | 348.77 Million CNY | 3.19% |
| 2022 Q4 | 16.8 Million CNY | -88.5% |
| 2022 Q1 | 91.73 Million CNY | 44.7% |
| 2022 Q2 | 89.34 Million CNY | -2.6% |
| 2022 Q3 | 146.13 Million CNY | 63.56% |
| 2021 Q3 | 127.27 Million CNY | 65.59% |
| 2021 FY | 337.99 Million CNY | 21.38% |
| 2021 Q1 | 70.45 Million CNY | 42.86% |
| 2021 Q2 | 76.86 Million CNY | 9.1% |
| 2021 Q4 | 63.39 Million CNY | -50.19% |
| 2020 Q1 | 41.36 Million CNY | -20.01% |
| 2020 FY | 278.44 Million CNY | -6.65% |
| 2020 Q4 | 49.31 Million CNY | -59.6% |
| 2020 Q3 | 122.07 Million CNY | 85.85% |
| 2020 Q2 | 65.68 Million CNY | 58.78% |
| 2019 FY | 298.29 Million CNY | 28.09% |
| 2019 Q4 | 51.71 Million CNY | -55.46% |
| 2019 Q3 | 116.1 Million CNY | 80.45% |
| 2019 Q2 | 64.34 Million CNY | -2.72% |
| 2019 Q1 | 66.13 Million CNY | 51.88% |
| 2018 Q1 | 51.95 Million CNY | 38.12% |
| 2018 Q4 | 43.54 Million CNY | -49.01% |
| 2018 FY | 232.88 Million CNY | 25.14% |
| 2018 Q3 | 85.39 Million CNY | 64.27% |
| 2018 Q2 | 51.98 Million CNY | 0.06% |
| 2017 Q1 | 38.2 Million CNY | 43.52% |
| 2017 Q2 | 40.52 Million CNY | 6.06% |
| 2017 Q3 | 69.75 Million CNY | 72.15% |
| 2017 Q4 | 37.61 Million CNY | -46.08% |
| 2017 FY | 186.1 Million CNY | 44.04% |
| 2016 FY | 129.2 Million CNY | 9.66% |
| 2016 Q1 | 28.47 Million CNY | 7.25% |
| 2016 Q2 | 25.65 Million CNY | -9.92% |
| 2016 Q3 | 48.44 Million CNY | 88.87% |
| 2016 Q4 | 26.62 Million CNY | -45.05% |
| 2015 FY | 117.82 Million CNY | 18.35% |
| 2015 Q4 | 26.55 Million CNY | -33.51% |
| 2015 Q3 | 39.93 Million CNY | 47.01% |
| 2015 Q2 | 27.16 Million CNY | 12.4% |
| 2015 Q1 | 24.16 Million CNY | -1.18% |
| 2014 Q1 | 13.34 Million CNY | -7.81% |
| 2014 Q4 | 24.45 Million CNY | -31.6% |
| 2014 Q3 | 35.75 Million CNY | 37.58% |
| 2014 Q2 | 25.99 Million CNY | 94.7% |
| 2014 FY | 99.55 Million CNY | 41.08% |
| 2013 Q1 | 16.11 Million CNY | 20.54% |
| 2013 FY | 70.56 Million CNY | 31.22% |
| 2013 Q4 | 14.47 Million CNY | -41.03% |
| 2013 Q3 | 24.55 Million CNY | 59.29% |
| 2013 Q2 | 15.41 Million CNY | -4.34% |
| 2012 FY | 53.77 Million CNY | 44.3% |
| 2012 Q4 | 13.36 Million CNY | -35.54% |
| 2012 Q3 | 20.73 Million CNY | 0.0% |
| 2011 FY | 37.26 Million CNY | 102.46% |
| 2010 FY | 18.4 Million CNY | 75.07% |
| 2009 FY | 10.51 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 488.73 Million CNY | 36.533% |
| Zhejiang Zhenyuan Share Co., Ltd. | 81.64 Million CNY | -279.93% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -215.14 Million CNY | 244.175% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -140.24 Million CNY | 321.169% |
| Yifan Pharmaceutical Co., Ltd. | -551.07 Million CNY | 156.287% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 34.32 Million CNY | -803.796% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.45 Billion CNY | 87.371% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -8.92 Million CNY | 3574.555% |
| Boai NKY Medical Holdings Ltd. | 493.02 Million CNY | 37.086% |